Penumbra Other Operating Expenses vs Research Development Analysis

PEN Stock

USD 244.12 0.03 0.01%

Penumbra financial indicator trend analysis is much more than just breaking down Penumbra prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Penumbra is a good investment. Please check the relationship between Penumbra Other Operating Expenses and its Research Development accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Penumbra. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.

Other Operating Expenses vs Research Development

Other Operating Expenses vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Penumbra Other Operating Expenses account and Research Development. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Penumbra's Other Operating Expenses and Research Development is 0.85. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Research Development in the same time period over historical financial statements of Penumbra, assuming nothing else is changed. The correlation between historical values of Penumbra's Other Operating Expenses and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Penumbra are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Other Operating Expenses i.e., Penumbra's Other Operating Expenses and Research Development go up and down completely randomly.

Correlation Coefficient

0.85

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Penumbra. It is also known as Penumbra overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Research Development

Most indicators from Penumbra's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Penumbra current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Penumbra. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.At this time, Penumbra's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 29th of November 2024, Enterprise Value is likely to grow to about 10.2 B, while Selling General Administrative is likely to drop about 266.2 M.

	2021	2022	2023	2024 (projected)
Gross Profit	475.4M	535.2M	682.6M	716.8M
Total Revenue	747.6M	847.1M	1.1B	1.1B

Gross Profit Total Revenue

Penumbra fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross
Common Stock Shares Outstanding		0.73	0.65	0.7	0.81	0.74	0.44	0.69	0.49	0.4	0.66	0.72	0.66	0.68	0.57	0.69	0.75	0.75	0.72	0.62	0.51	0.71	0.76	0.82	0.65	0.67
Total Assets	0.73		0.9	0.83	0.91	1.0	0.03	0.98	0.11	0.72	0.92	0.97	0.9	0.98	0.93	0.73	0.79	0.99	0.76	0.65	0.84	0.99	1.0	0.98	0.94	0.98
Short Long Term Debt Total	0.65	0.9		0.83	0.89	0.89	0.02	0.88	-0.01	0.72	0.73	0.86	0.73	0.89	0.78	0.63	0.76	0.89	0.78	0.62	0.77	0.88	0.87	0.88	0.85	0.86
Other Current Liab	0.7	0.83	0.83		0.87	0.84	0.1	0.77	0.19	0.57	0.64	0.74	0.67	0.8	0.73	0.85	0.82	0.8	0.75	0.7	0.62	0.82	0.83	0.85	0.73	0.75
Total Current Liabilities	0.81	0.91	0.89	0.87		0.91	0.13	0.9	0.3	0.69	0.77	0.89	0.76	0.88	0.75	0.85	0.85	0.92	0.83	0.69	0.72	0.89	0.91	0.92	0.85	0.87
Total Stockholder Equity	0.74	1.0	0.89	0.84	0.91		0.09	0.96	0.16	0.68	0.91	0.95	0.91	0.96	0.91	0.75	0.83	0.98	0.81	0.7	0.79	0.99	0.99	0.99	0.91	0.96
Other Liab	0.44	0.03	0.02	0.1	0.13	0.09		-0.1	0.8	-0.49	0.01	0.03	0.17	-0.1	-0.19	0.08	0.44	0.06	0.45	0.47	-0.34	-0.02	0.03	0.14	-0.18	-0.11
Property Plant And Equipment Net	0.69	0.98	0.88	0.77	0.9	0.96	-0.1		0.02	0.81	0.91	0.97	0.87	0.99	0.93	0.7	0.69	0.98	0.67	0.53	0.91	0.99	0.98	0.95	0.98	1.0
Current Deferred Revenue	0.49	0.11	-0.01	0.19	0.3	0.16	0.8	0.02		-0.34	0.11	0.15	0.22	-0.04	-0.09	0.46	0.54	0.16	0.47	0.56	-0.22	0.1	0.13	0.21	-0.04	-0.01
Net Debt	0.4	0.72	0.72	0.57	0.69	0.68	-0.49	0.81	-0.34		0.54	0.7	0.42	0.82	0.67	0.5	0.31	0.71	0.32	0.21	0.86	0.72	0.72	0.67	0.83	0.78
Retained Earnings	0.66	0.92	0.73	0.64	0.77	0.91	0.01	0.91	0.11	0.54		0.93	0.97	0.89	0.95	0.61	0.69	0.91	0.64	0.48	0.8	0.93	0.93	0.89	0.88	0.94
Accounts Payable	0.72	0.97	0.86	0.74	0.89	0.95	0.03	0.97	0.15	0.7	0.93		0.91	0.94	0.91	0.69	0.72	0.99	0.72	0.54	0.86	0.98	0.96	0.94	0.95	0.97
Cash	0.66	0.9	0.73	0.67	0.76	0.91	0.17	0.87	0.22	0.42	0.97	0.91		0.85	0.92	0.6	0.74	0.9	0.7	0.55	0.73	0.92	0.91	0.88	0.83	0.9
Non Current Assets Total	0.68	0.98	0.89	0.8	0.88	0.96	-0.1	0.99	-0.04	0.82	0.89	0.94	0.85		0.93	0.66	0.68	0.96	0.66	0.53	0.91	0.98	0.98	0.95	0.97	0.99
Non Currrent Assets Other	0.57	0.93	0.78	0.73	0.75	0.91	-0.19	0.93	-0.09	0.67	0.95	0.91	0.92	0.93		0.62	0.62	0.91	0.55	0.43	0.88	0.95	0.93	0.88	0.93	0.96
Other Assets	0.69	0.73	0.63	0.85	0.85	0.75	0.08	0.7	0.46	0.5	0.61	0.69	0.6	0.66	0.62		0.8	0.73	0.71	0.72	0.5	0.74	0.74	0.77	0.65	0.67
Cash And Short Term Investments	0.75	0.79	0.76	0.82	0.85	0.83	0.44	0.69	0.54	0.31	0.69	0.72	0.74	0.68	0.62	0.8		0.77	0.96	0.93	0.4	0.76	0.78	0.83	0.59	0.68
Net Receivables	0.75	0.99	0.89	0.8	0.92	0.98	0.06	0.98	0.16	0.71	0.91	0.99	0.9	0.96	0.91	0.73	0.77		0.76	0.61	0.84	0.99	0.99	0.97	0.94	0.97
Common Stock Total Equity	0.72	0.76	0.78	0.75	0.83	0.81	0.45	0.67	0.47	0.32	0.64	0.72	0.7	0.66	0.55	0.71	0.96	0.76		0.9	0.34	0.73	0.74	0.81	0.54	0.65
Short Term Investments	0.62	0.65	0.62	0.7	0.69	0.7	0.47	0.53	0.56	0.21	0.48	0.54	0.55	0.53	0.43	0.72	0.93	0.61	0.9		0.2	0.6	0.62	0.7	0.41	0.5
Non Current Liabilities Total	0.51	0.84	0.77	0.62	0.72	0.79	-0.34	0.91	-0.22	0.86	0.8	0.86	0.73	0.91	0.88	0.5	0.4	0.84	0.34	0.2		0.86	0.85	0.78	0.97	0.91
Inventory	0.71	0.99	0.88	0.82	0.89	0.99	-0.02	0.99	0.1	0.72	0.93	0.98	0.92	0.98	0.95	0.74	0.76	0.99	0.73	0.6	0.86		0.99	0.97	0.95	0.99
Other Current Assets	0.76	1.0	0.87	0.83	0.91	0.99	0.03	0.98	0.13	0.72	0.93	0.96	0.91	0.98	0.93	0.74	0.78	0.99	0.74	0.62	0.85	0.99		0.98	0.95	0.98
Other Stockholder Equity	0.82	0.98	0.88	0.85	0.92	0.99	0.14	0.95	0.21	0.67	0.89	0.94	0.88	0.95	0.88	0.77	0.83	0.97	0.81	0.7	0.78	0.97	0.98		0.9	0.94
Total Liab	0.65	0.94	0.85	0.73	0.85	0.91	-0.18	0.98	-0.04	0.83	0.88	0.95	0.83	0.97	0.93	0.65	0.59	0.94	0.54	0.41	0.97	0.95	0.95	0.9		0.98
Property Plant And Equipment Gross	0.67	0.98	0.86	0.75	0.87	0.96	-0.11	1.0	-0.01	0.78	0.94	0.97	0.9	0.99	0.96	0.67	0.68	0.97	0.65	0.5	0.91	0.99	0.98	0.94	0.98

Click cells to compare fundamentals

Penumbra Account Relationship Matchups

Penumbra fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	36.3M	35.8M	37.9M	37.8M	39.2M	34.8M
Total Assets	665.9M	823.0M	1.2B	1.4B	1.6B	1.6B
Other Current Liab	4.3M	79.8M	89.8M	85.2M	103.6M	55.2M
Total Current Liabilities	91.0M	105.9M	123.2M	144.9M	151.1M	83.5M
Total Stockholder Equity	485.9M	641.5M	953.9M	998.9M	1.2B	1.2B
Other Liab	15.3M	8.0M	3.6M	3.3M	3.8M	3.6M
Property Plant And Equipment Net	135.5M	127.4M	227.1M	291.0M	300.4M	315.5M
Net Debt	9.5M	7.6M	114.2M	165.9M	66.9M	70.2M
Retained Earnings	57.5M	40.6M	45.9M	43.9M	134.9M	141.6M
Accounts Payable	15.1M	14.1M	13.4M	26.7M	27.2M	28.5M
Cash	72.8M	69.7M	59.4M	69.9M	167.5M	175.9M
Non Current Assets Total	202.8M	205.3M	562.8M	615.2M	640.9M	672.9M
Non Currrent Assets Other	2.9M	8.7M	13.0M	12.8M	25.9M	27.2M
Other Assets	34.3M	138.1M	78.7M	77.0M	88.6M	47.4M
Cash And Short Term Investments	189.4M	264.8M	254.9M	188.0M	289.2M	194.5M
Net Receivables	105.9M	114.6M	133.9M	203.4M	201.8M	211.9M
Common Stock Total Equity	35K	36K	37K	38K	43.7K	31.1K
Short Term Investments	116.6M	195.2M	195.5M	118.2M	121.7M	134.7M
Liabilities And Stockholders Equity	665.9M	823.0M	1.2B	1.4B	1.6B	1.6B
Non Current Liabilities Total	89.2M	79.3M	167.1M	227.1M	226.2M	237.5M
Inventory	153.0M	219.5M	263.5M	334.0M	388.0M	407.4M
Other Current Assets	14.9M	18.7M	29.2M	30.3M	36.4M	38.2M
Other Stockholder Equity	430.7M	598.3M	910.6M	963.0M	1.0B	1.1B
Total Liab	180.3M	185.2M	290.3M	372.0M	377.4M	396.2M
Property Plant And Equipment Gross	135.5M	127.4M	227.1M	291.0M	352.2M	369.8M
Total Current Assets	463.1M	617.7M	681.5M	755.7M	915.4M	491.2M
Accumulated Other Comprehensive Income	(2.3M)	2.5M	(2.6M)	(8.1M)	(3.2M)	(3.0M)
Common Stock	35K	36K	37K	38K	39K	32.2K
Property Plant Equipment	131.9M	48.2M	227.1M	291.0M	334.6M	351.4M
Net Tangible Assets	449.3M	622.5M	696.9M	751.7M	864.4M	459.5M
Deferred Long Term Liab	6.2M	7.6M	5.8M	5.1M	5.9M	4.9M
Good Will	7.7M	8.4M	166.4M	166.0M	166.3M	174.6M
Retained Earnings Total Equity	57.5M	40.6M	45.9M	43.9M	50.5M	53.0M
Capital Surpluse	430.7M	598.3M	910.6M	963.0M	1.1B	583.1M
Non Current Liabilities Other	11.2M	79.3M	3.6M	3.3M	5.3M	5.0M
Intangible Assets	25.4M	10.6M	90.6M	81.2M	63.2M	39.4M
Long Term Debt Total	26.7M	27.1M	26.5M	24.9M	28.6M	16.5M

When determining whether Penumbra offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Penumbra's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Penumbra Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Penumbra Stock:

How To Invest In Penumbra

Details

Is Penumbra Stock a good investment?

Details

What is Penumbra's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Penumbra. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.

You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Penumbra. If investors know Penumbra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Penumbra listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

2.261

Earnings Share

0.88

Revenue Per Share

30.081

Quarterly Revenue Growth

0.111

Return On Assets

0.0333

The market value of Penumbra is measured differently than its book value, which is the value of Penumbra that is recorded on the company's balance sheet. Investors also form their own opinion of Penumbra's value that differs from its market value or its book value, called intrinsic value, which is Penumbra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Penumbra's market value can be influenced by many factors that don't directly affect Penumbra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Penumbra's value and its price as these two are different measures arrived at by different means. Investors typically determine if Penumbra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Penumbra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Penumbra Other Operating Expenses vs Research Development Analysis

Other Operating Expenses vs Research Development

Other Operating Expenses vs Research Development Correlation Analysis

Correlation Coefficient

Other Operating Expenses

Research Development

Penumbra fundamental ratios Correlations

Penumbra Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Penumbra fundamental ratios Accounts

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Other Current Assets	+ 1.0	Total Assets
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Net Receivables	+ 0.99	Total Assets
Inventory	+ 0.99	Total Assets
Inventory	+ 0.99	Total Stockholder Equity

Net Debt	- 0.49	Other Liab
Net Debt	- 0.34	Current Deferred Revenue
Non Current Liabilities Total	- 0.34	Other Liab
Non Current Liabilities Total	- 0.22	Current Deferred Revenue
Non Currrent Assets Other	- 0.19	Other Liab
Total Liab	- 0.18	Other Liab